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Abstract The interaction of stem cell factor (SCF) with
its cognate receptor c-Kit is closely associated with the
survival and maturation of melanocytes. To investigate
novel depigmentation agents, we screened 2,000 plant
extracts for c-Kit inhibitors to identify active small mole-
cules by using time-resolved fluorescence enzyme assays.
For the active extracts identified as inhibitors of c-Kit
enzyme, we evaluated the effects of the active extracts and
isolated flavonoids on c-Kit phosphorylation in MO7e/
melanocytes. Anti-melanogenic activity was also examined
in melanocytes and melanoderm model. The flavonoids
such as diosmetin, apigenin, acacetin and luteolin isolated
from Chrysanthemum morifolium were found to be active
in inhibiting c-Kit both at enzyme and cellular levels. In
addition, these flavonoids attenuated SCF-induced prolif-
eration of human primary melanocytes without toxicity and
suppressed ultraviolet (UV) B irradiation-mediated mela-
nin synthesis significantly. Among the active flavonoids,
diosmetin was found to inhibit SCF-induced melanogenesis
in a human melanoderm model. These results strongly
suggest that C. morifolium extract and diosmetin have
potential to suppress SCF-/UVB-induced melanogenesis,
and could be developed as anti-pigmentation agents.
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Abbreviations
SCF Stem cell factor
UVB Ultraviolet B
BL Butanol layer of C. morifolium extract
DOPA L-dihydroxyphenyl-alanine
Introduction
The association of stem-cell factor (SCF, steel factor) with
its receptor c-Kit (CD-117, Kit) mediates signaling that is
critical for melanocyte survival, proliferation, differentia-
tion, and migration (Alexeev and Yoon 2006; Halaban
2000; Wehrle-Haller 2003). The binding of SCF to c-Kit
induces autophosphorylation on tyrosines in the COOH-
terminus of c-Kit, which activates its kinase (Mol et al.
2004; Roskoski 2005). In connection with cell survival,
c-Kit activates multiple downstream signaling pathways,
including the Ras/Raf/mitogen-activated protein kinase
kinase (MAPKK)/mitogen-activated protein kinase
(MAPK) pathway and the phosphatidylinositol 3-kinase
(PI3K)/protein kinase B (AKT) pathway (Hemesath et al.
1998; Roskoski 2005). Furthermore, the over-expression or
mutation of c-Kit has been observed in many human solid
tumors (Hirota et al. 1998). Consequently, c-Kit has been
extensively studied as a target in anticancer drug devel-
opment and as a key protein in melanogenesis (Attoub
et al. 2002; Kato et al. 2004).
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Studies with transgenic mice that carried SCF under the
keratin promoter showed that SCF promoted the migration
of melanocytes out of niches. When these mice were
treated with a c-Kit antibody (ACK2), their progeny had
white (unpigmented) skin and hair (Nishimura et al. 2002).
Interestingly, a few reports have shown that patients treated
with imatinib (Gleevec) exhibited onset of hypopigmenta-
tion (Brazzelli et al. 2007; Tsao et al. 2003).
Melanogenesis is generally up-regulated by ultravio-
let (UV) light. UV light exerts its effects directly on
melanocytes or keratinocyte-derived factors (Hirobe
2005). SCF/c-Kit signaling also plays a key role in the
early phase of melanocyte activation during UVB-
induced pigmentation (Hachiya et al. 2001; Hosaka
et al. 2004; Tobiishi et al. 2005). Exposure to UV or
treatment with SCF increases the number of melano-
cytes in the dermis, mainly through the c-Kit-mediated
signaling cascade (Kawaguchi et al. 2001). Once acti-
vated, c-Kit phosphorylates the microphthalmia-asso-
ciated transcription factor (MITF) via mitogen-activated
protein kinase (MAPK); subsequently, the phosphory-
lated MITF promotes melanocyte maturation (Hemesath
et al. 1998; Tachibana 2000). Therefore, blocking c-Kit
signaling can radically prevent pigment formation
through inhibition of both melanoblast differentiation
and melanogenesis, rather than simply by inhibiting
tyrosinase transcription.
Several small molecules have been developed or docu-
mented as whitening agents, including hydroquinone, kojic
acid, arbutin, ascorbic acid, and retinoic acid. Currently,
most whitening agents used in both the cosmetic and
medical markets inhibit the activity of tyrosinase (Briganti
et al. 2003).
Recently, we isolated emodin as a suppressor of c-Kit
signaling by screening a synthetic library based on natu-
rally occurring compounds (Lee et al. 2009). Here, we
screened 2,000 plant extracts for c-Kit inhibitory activity
and isolated anti-melanogenic flavonoids. Flavonoids are
natural polyphenolic compounds that are reported to have
anti-oxidative and kinase-inhibitory effects. For example,
the flavonoids, quercetin, luteolin, and genistein, were
shown to inhibit the kinase activities of epithelial growth
factor receptor (EGFR), protein kinase C (PKC), and focal
adhesion kinase (FAK) (Agullo et al. 1997; Huang et al.
1999; Kandaswami et al. 2005). Several recent reports have
also described the diverse effects that flavonoids have on
melanogenesis in human skin and other cell lines (An et al.
2008; Nagata et al. 2004; Ohguchi et al. 2006), however,
the mechanism of action for c-Kit is unclear. In this study,
we investigated whether flavonoids from Chrysanthemum




All the chemicals, except those specifically mentioned,
were purchased from either CalBiochem (CA, USA) or
Sigma Co. Ltd (MO, USA). The intracellular domain of the
c-Kit protein was obtained from ProQinase (Germany).
Kinase substrates were purchased from PerkinElmer (MA,
USA) and anti-c-Kit antibody (pY719 and total-c-Kit) were
obtained from Cell Signaling (MA, USA). The platelet-
derived growth factor receptor (PDGFR) tyrosine kinase
inhibitor III, 4-(6,7-dimethoxy-4-quinazolinyl)-N-(4-phen-
oxy phenyl)-1-piperazinecarboxamide, (521232, CalBio-
chem, CA) was used as a reference c-Kit inhibitor.
In vitro time-resolved fluorescence (TRF) kinase assay
The inhibition of c-Kit (N-terminal GST-tagged recombi-
nant human Kit, amino acid T544-V976 expressed by
baculovirus system in Sf9 insect cells, ProQinase) was
determined in a TRF assay. Briefly, c-Kit (20 ng/well)
was incubated for 30 min at room temperature (RT)
with 1.5 lM of peptide substrate (Biotin-VEEEA-
PEDLYKDFLTLEH, synthesized in Peptron, Daejeon,
Korea), 10 lM ATP, and compounds to be tested for
inhibition in a buffer containing 50 mM Tris (pH 7.5),
5 mM MgCl2, 5 mM MnCl2, 2 mM DTT, and 0.01 %
Tween-20. The reaction mixture was transferred into a
streptavidin-coated DELFIA 96-well plate (PerkinElmer)
and incubated for 1 h. After washing 3 times with PBS/T
(pH 7.0), the plates were further incubated with anti-
phosphotyrosine (p-Y-100) antibody for 1 h and with
Europium-labeled secondary anti-mouse antibody for
30 min; then the plate was rinsed again three times with
PBS/T. Finally, Europium Enhancement Solution (Perkin-
Elmer) was applied, and the TRF signal was measured in a
Victor2 microplate reader (PerkinElmer). All experiments
were performed in duplicate. IC50 values were obtained from
a nonlinear regression analysis with GraphPad Prism version
5.0 for Windows (GraphPad Software, San Diego, CA).
AlphaBead kinase assay
Kinase activity was also determined using AlphaScreenTM
phosphotyrosine (P-Tyr-100) assay kit (PerkinElmer,
CT, USA). ALPHA (Amplified Luminescent Proximity
Homogeneous Assay) is a bead-based immunoassay mon-
itoring the energy transfer from streptavidin-coated donor
bead to anti-phosphotyrosine antibody conjugated acceptor
bead. The kinase assay was performed according to the
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protocol provided by the manufacturer. Briefly, kinase (5 lL,
2.5–10 ng) was incubated with 5 lL of kinase reaction buffer
(50 mM Tris–HCl (pH 7.5), 5 mM MgCl2, 5 mM MnCl2,
2 mM DTT and 0.01 % Tween-20) containing a compound to
be tested in a 384-well plate for 15 min at RT. Then, 5 lL of
the reaction buffer containing biotinylated poly[Glu:Tyr](4:1)
substrate (final conc. 5 nM) and ATP (final conc. 10 lM)
were added and allowed to stand at RT for 1 h. The reaction
was quenched by the addition of the capture buffer containing
EDTA 100 mM, NaCl 250 mM, 62.5 mM HEPES, donor-
streptavidin and acceptor P-Tyr-100 beads (final conc.
20 lM). After 1 h incubation at RT, AlphaScreen signal was
detected in FusionTM microplate analyzer (PerkinElmer). All
the assays were performed in white 384-well plates (Greiner
Bio-One, Germany) in a final volume of 25 lL.
Cell culture
All mammalian cells were grown in an appropriate culture
media containing antibiotics (100 U/mL penicillin and
100 lg/mL streptomycin) in a humidified incubator under
5 % CO2 at 37 C. MO7e cells (M-07 human megakaryocytic
leukemia cell line) were generously provided by Dr. Young-
Hee Lee (Chung-buk National University, Chungju, Korea).
Primary melanocytes were obtained from circumcised tissue
from a newborn baby. NCCmelan5 cells (mouse melanocyte
cell line) were kindly donated by Dr. Mizoguchi and Yoko
Kawa (St. Marianna University, Japan (Ooka et al. 2001)).
MO7e cells were routinely propagated in Iscove’s Modified
Dulbecco’s Medium (GIBCO, CA, USA), supplemented with
heat-inactivated 10 % FBS and 1 ng/mL granulocyte mac-
rophage colony stimulating factor (GM-CSF). NCCmelan5
cells were grown in Eagle’s minimum essential medium
(EMEM; GIBCO) supplemented with 15 % FBS, 50 ng/mL
murine stem cell factor (mSCF; CHEMICON), and 100 nM
endothelin 3 (EDN3). SK-mel2 cells were cultured in RPMI
media supplemented with 10 % heat-inactivated FBS. Human
primary melanocytes were maintained in MCDB153 media
(Sigma, MO, USA) supplemented with 1 % FBS, 10 ng/mL
phorbol 12-myristate 13-acetate (TPA), 5 lg/mL insulin,
0.5 lg/mL hydrocortisone, 1 ng/mL basic fibroblast growth
factor (bFGF), 10 nM alpha-melanocyte stimulating hormone
(a-MSH), and 1 lg/mL transferrin.
Western blot analysis
For Western blot analysis, cells were seeded at 70 % con-
fluence in 6-cm dishes and deprived of cytokines in media
supplemented with 1 % FBS for about 16 h. Subsequently,
the test compounds were added for 45 min. Then the cells
were stimulated with 50 ng/mL SCF for 10 min. To prepare
the whole cell lysates, cells were washed twice with PBS
and lysed. Then, cell lysates were electrophoretically
separated on a 6 % SDS–polyacrylamide gel. Proteins were
transferred onto Immobilon P-PVDF membranes (polyvi-
nylidene fluoride, Millipore, MA, USA) overnight at 4 C.
Membranes were blocked with TBS containing 5 % skim
milk and 0.1 % Tween 20, pH 7.4 for 1 h and then incu-
bated sequentially with primary and secondary antibodies
diluted in blocking buffer. Protein bands were detected with
an enhanced chemiluminescence detection system (Cell
Signaling, MA, USA) on a LAS-3000 (Fuji, Japan).
Isolation of diosmetin from C. morifolium
The air-dried flowers of C. morifolium were treated with
100 % methanol using the reflux method. The resulting
methanol extract of C. morifolium was successively frac-
tionated with n-hexane, chloroform, and n-butanol. Then,
the n-butanol fraction of C. morifolium was separated by
silica gel column chromatography with chloroform–meth-
anol (20:1 * 2:1) to yield ten fractions. Effective fractions
were purified by preparative HPLC (MERCK/SEPTECH)
using a reverse phase column (CombiHT SB-18, 5 lm,
21.2 mm 9 150 mm) and acetonitrile (35 * 50 %) to
yield four fractions Y1, Y2, Y3 and Y4, which were
identified as acacetin, diosmetin, apigenin, and luteolin,
respectively, by comparing NMR spectroscopic data with
the previously reported ones (Cai et al. 2000; Christo-
phoridou et al. 2005; Kraus et al. 2008; Seijas et al. 2005)
MTT and [3H]-thymidine incorporation assays
Cytotoxic effects were evaluated with a MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide;
thiazolyl blue) viability assay. The MTT assay is a standard
colorimetric assay that measures the activity of enzymes
that reduce MTT to insoluble purple formazan crystals.
Cells were seeded on 96-well plates at a density of 1 9 104
cells per well and treated with the test compounds at var-
ious concentrations for 48 h. Ten microliters of 5 mg/mL
MTT solution was added and cells were incubated for 1 h.
The medium was aspirated and 100 lL of DMSO was
added to each well. After 10 min of incubation, the
absorbance was measured at 570 nm.
Changes in cell proliferation were measured with a [3H]-
thymidine incorporation assay. Cells were seeded at a
density of 5 9 103 cells per well on a 96-well plate. The
next day, cells were pre-incubated with the test compounds
for 1 h and then stimulated with SCF (100 ng/mL) for
another 6 h. [3H]-Thymidine was added at 0.05 lCi per
well and cells were further incubated for 48 h. After the
cells were rinsed three times with PBS, a scintillation
cocktail was added. Incorporated radioactive thymidine
was counted on a MicroBeta scintillation counter
(PerkinElmer).
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[14C]-tyrosine incorporation assay
Melanin content was assessed with radioactive tyrosine.
Melanocytes were seeded on 96-well plates at a density of
1 9 104 cells per well. The cells were allowed to stabilize
for 24 h, then they were treated with the test compounds
for 1 h, and then stimulated with 100 ng/mL of SCF or
30 mJ of UVB (312 nm) with a BIO-SUN irradiator
(Vilber Lourmat, France). [14C]-tyrosine (Amersham Phar-
macia Biotech, England) was added at 0.03 lCi per well and
cells were incubated for 48 h. After the cells were washed
with PBS three times, the radioisotope taken up by the cells
was measured in a MicroBeta (PerkinElmer).
DOPA assay
Pigments synthesized from L-dihydroxyphenyl-alanine
(DOPA) were visualized after DOPA supplementation.
Melanocytes were serum-starved for 18 h; then, they were
either irradiated with 30 mJ UVB or treated with SCF
(100 ng/mL). Cells were incubated with the test compound
or the reference compound for 48 h. After the medium was
exchanged with serum-free media, cells were treated with
10 mM DOPA (Sigma Chemicals Co.) for 3 h at 37 C.
After removing the cell media, crystal mount was dropped
on top of the cells and subsequently, cells were dried at
50 C. Photos were taken in an inverted microscope (409
or 1009). The melanin content (total intensity ±S.D.) in
each photo was analyzed with the image program Meta-
Morph (Molecular Devices).
MelanoDerm assay
MelanoDermTM (MEL-300-A-LLMM, MatTek, USA) is a
human three-dimensional tissue model. This tissue model
was used to test the effect of diosmetin against SCF.
Melanoderm tissue was transferred into a 6-well plate with
a cell culture insert atop a culture stand (MEL-STND). The
culture medium contained pre-warmed EPI-100-LLMM
(0.9 mL) and was placed below the cell insert to feed the
basolateral side of the cells; 100 ll of PBS was placed on
top of the cell inserts. EPI-100-LLMM (MatTak) is a
commercial DMEM-based medium that contains a-MSH,
bFGF, EGFR, insulin, hydrocortisone, and other proprie-
tary stimulators of epidermal differentiation. Cells were
incubated in SCF (200 ng/mL) for three days; then, com-
pounds were applied for 2 more weeks. Fresh medium
(5 mL) was applied to the basolateral side of the tissue
every other day. Melanoderms were fixed with 10 % for-
malin and photos were taken from the top-view with a
phase contrast microscope at 1009 magnification.
Results
Inhibition of c-Kit phosphorylation by C. morifolium
In search of c-Kit inhibitors, we evaluated 2,000 plant
extracts with an enzymatic c-Kit assay. Twenty-one plant
extracts showed[70 % inhibition of c-Kit phosphorylation
in vitro (data not shown). These 21 plant extracts were
Fig. 1 Plant extracts were
tested for inhibition of c-Kit
phosphorylation in MO7e cells.
a Twenty-one hit samples
selected from a c-Kit enzyme
assay were tested on MO7e
cells. Cells were pre-treated
with the indicated natural
extracts for 45 min, and then
treated with 50 ng/mL SCF for
10 min. In the immunoblot
analysis, phosphorylated c-Kit
was detected with anti-phospho
(Y719) antibody. b The selected
C. morifolium extract was
further tested at the indicated
concentrations. R is the
reference inhibitor (521232,
10 lM)
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tested to determine whether they could block SCF-induced
cellular c-Kit activation in megakaryocytic leukemia
(MO7e) cells. Cells were pretreated with the indicated
natural extracts and then treated with SCF. Phosphorylated
c-Kit (pY719) was assessed in cells treated with or without
SCF (Fig. 1). Downstream from c-Kit phosphorylation,
Fig. 2 Anti-pigmentation effect of the BL from the C. morifolium
extract. a [14C]-tyrosine incorporation was determined in NCCmelan5
cells after 48 h treatments with SCF (100 ng/mL). b [14C]-tyrosine
incorporation was determined in NCCmelan5 cells 48 h after UVB-
irradiation (30 mJ). c Representative data from DOPA assay after
UVB-irradiation of NCCmelan5 cells. After exposure to SCF, cells
were pretreated with the indicated concentrations of the BL and
incubated for 48 h. The DOPA assay was performed, and the photos
(9100) were taken with an inverted microscope. d DOPA assay in
NCCmelan5 cells 18 h after stimulation with 30 mJ of UVB. Cells
were incubated with the BL fraction for 48 h. After the medium was
exchanged with serum-free media, the DOPA assay was performed
and photos were taken at 940 magnification. The R is the reference
inhibitor (521232, 3 lM). The pigment areas of melanocytes were
quantitated using program MetaMorph from three independent
experiments (c & d right panels)
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extracellular signal-regulated kinase (ERK) responded
consistently (data not shown). At the initial test concen-
tration (30 ppm), only two extracts (serial numbers 13 and
16; C. morifolium and Panax japonicus) showed significant
inhibition of c-Kit phosphorylation. The C. morifolium
extract was selected for further purification because it
showed the most potent dose-dependent inhibition of cell-
based c-Kit phosphorylation in MO7e cells. Among the
two fractions separated from the C. morifolium extract, the
butanol layer (BL) exhibited higher inhibitory activity for
c-Kit phosphorylation than the water layer. Therefore, the
BL was submitted to chromatography with a silica gel
column and then fractions were separated with preparative
HPLC in reverse phase.
Chrysanthemum morifolium extract suppressed
SCF-/UVB-induced pigmentation
Pigments like eumelanin and pheomelanin are synthesized
from tyrosine and DOPA (Sugumaran 2002). In our study,
melanin synthesis was monitored by both tyrosine and
DOPA incorporation assays. With exposure to 30 ppm of
the BL fraction, SCF-induced melanin synthesis was
completely blocked, and total synthesis was reduced by
half (Fig. 2a, c). Furthermore, we tested whether the
extract of C. morifolium could inhibit UVB-induced pig-
mentation since SCF/c-Kit signaling is activated in the
early phase of melanogenesis during UVB irradiation. The
increased pigment formation induced by UVB irradiation
(30 mJ, a single dose) was also attenuated by treatment with
the BL fraction at a concentration of 30 ppm in mouse mel-
anocytes and human melanoma SK-mel2 cells (Fig. 2b, d).
Identification of flavonoids from C. morifolium
that inhibit c-Kit
All four of the compounds (Y1 * Y4) isolated from the BL
fraction by HPLC showed effective inhibition of c-Kit
phosphorylation in mouse melanocytes at 0.3 * 1.0 ppm
(Fig. 3a). The separated compounds from the concentrated
four fractions were identified as acacetin, diosmetin, apige-
nin, and luteolin by NMR and mass spectrometry analysis.
Enzyme inhibitory activities of the isolated compounds were
confirmed with AlphaBead kinase assay in vitro. In enzy-
matic assay, Luteolin demonstrated the strongest inhibitory
Fig. 3 Four compounds isolated from C. morifolium were tested for
inhibition of c-Kit phosphorylation in mouse melanocytes. a Cells
were pre-treated for 45 min with BL (0.3 ppm) and the four final
fractions Y1 * Y4 separated from BL. Then, 50 ng/mL of SCF was
added for 10 min. Phosphorylated c-Kit was detected with anti-
phospho (Y719) antibodies. b The structures of four active
compounds from fractions Y1 * Y4 purified from the BL of the
C. morifolium extract. c c-Kit enzyme inhibition by acacetin,
diosmetin, apigenin, and luteolin (AlphaBead assay). d Cell based
c-Kit inhibition by the four purified compounds in NCCmelan5 cells.
R is compound 521232 at 3 lM
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potency and the other three showed moderate inhibition:
IC50 = 1.0, 4.7, 12.1, and 13.3 lM for luteolin, apigenin,
diosmetin, and acacetin, respectively (Fig. 3c). However,
the cellular inhibitory potencies of the four flavonoids were
determined to be diosmetin (0.8 lM) [ acacetin, apigenin
(2.5 lM) [ luteolin (9.2 lM) in cultured NCCmelan5 cells
(Fig. 3d). The first three active flavonoids based on cellular
c-Kit inhibition were used in following studies with human
melanocytes.
SCF-induced proliferation of human melanocytes
was suppressed by diosmetin, apigenin, and acacetin
Cytotoxicity and anti-proliferative effects were determined
with MTT and [3H]-thymidine incorporation assays. The
three active flavonoids up to 10 lM did not affect cell
viability within 48 h, but a reference compound, 521232,
showed cytotoxicity at [3 lM (Fig. 4a). When cells were
treated with 100 ng/mL SCF, proliferation was accelerated
about 2-fold compared to untreated cells. However, the
SCF-stimulated proliferation was nearly blocked by pre-
incubations with 3 lM of diosmetin, apigenin, and acacetin
(Fig. 4b). Also, c-Kit inhibition experiment of the three
flavonoids in human melanocytes gave similar results
comparing to mouse melanocytes. Immunoblot analysis of
c-Kit phosphorylation showed that diosmetin was the most
potent c-Kit inhibitory flavonoid among these three com-
pounds; at 1 lM concentration diosmetin almost removed
the phosphorylated c-Kit band (Fig. 4c). Diosmetin, api-
genin, and acacetin also significantly reduced ERK phos-
phorylation induced by SCF stimulation.
Inhibition of melanin synthesis by diosmetin in human
melanocytes
Melanin synthesis of human melanocytes was induced
either by SCF treatment or UV irradiation. SCF-stimulated
melanin synthesis in human primary melanocytes was
remarkably reduced by the addition of diosmetin, apigenin,
or acacetin (Fig. 5a). In particular, diosmetin C3 lM)
completely blocked SCF-induced [14C]-tyrosine incorpo-
ration; thus, tyrosine was only incorporated at normal (SCF
non-treated) levels. Also, melanin synthesis induced by
UVB irradiation was partially blocked by these active
Fig. 4 The effect of flavonoids on SCF/c-Kit signaling in human
melanocytes. a The influence of SCF and flavonoids on viability of
human melanocytes was determined in 48 h. The MTT assay was
performed as described in the ‘‘Materials and Methods’’. b Prolifer-
ation of human melanocytes for 48 h was measured by [3H]-
thymidine incorporation assay. c Representative immunoblot analysis
of c-Kit and ERK after treatment with inhibitors. Compounds were
pretreated at the indicated concentrations for 45 min and 50 ng/mL of
SCF was applied for 10 min; then the Western blot was performed.
For detection of c-kit phosphorylation, we used anti-phospho-c-Kit
(p-Y-719), total-c-Kit, phospho-ERK (T202/Y204), or total-ERK
antibodies. R is the compound 521232 at 3 lM; values are expressed
as the mean values ±SD of three independent experiments
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flavonoids (Fig. 5b). Diosmetin, apigenin and acacetin
showed considerable suppression of the increased tyrosine-
incorporation by UVB irradiation. Both the tyrosine and
DOPA incorporation assays demonstrated consistent
results for the inhibitory potency of diosmetin, reflecting
the reduction of melanin content by diosmetin at C3 lM
(Fig. 5c). The same pattern was observed in mouse mela-
nocytes (data not shown).
Diosmetin showed effective anti-pigmentation activity
in a human melanoderm model
Diosmetin suppressed basal melanin synthesis and SCF-
induced pigmentation in the MelanoDermTM system, a
highly differentiated model of human epidermis that con-
sisted of multilayered epidermal keratinocytes and mela-
nocytes (Fig. 6). Diosmetin considerably lightened the tone
Fig. 5 Anti-pigmentation effect of flavonoids on human melano-
cytes. [14C]-tyrosine incorporation was induced by 100 ng/mL SCF
(a) or 30 mJ UVB (b) in human melanocytes. Cells were sequentially
treated with 3 lM of compounds and 0.03 lCi of [14C]-tyrosine for
48 h, and then processed for analysis. C. The SCF-induced pigmen-
tation was blocked by flavonoids in human melanocytes. Cells were
pre-treated with compounds, then incubated with 100 ng/mL of SCF
for 48 h. The photographs were taken under a microscope (9100)
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of the dermis compared to untreated controls. Kojic acid
(1 %), one of the most frequently used depigmentation
agents, was applied as a positive control. The concentration
of diosmetin and Kojic acid was determined from a pre-
liminary experiment. Diosmetin 60 lM (equal to 0.018 %)
showed effective prevention of SCF-induced melanogene-
sis in a MelanoDerm experiment performed for 2-weeks.
Discussion
SCF is an important factor that stimulates the proliferation
and melanogenesis of melanocytes and mediates the pig-
mentation response to UV irradiation (Imokawa 2004;
Kawaguchi et al. 2001). Blocking SCF/c-Kit signaling can
reduce differentiation of melanoblasts and proliferation of
melanocytes (Nishimura et al. 2002). Furthermore,
administration of small molecules that specifically inhib-
ited c-Kit showed inhibition of melanogenesis in mice,
brown guinea pigs, and human beings (Brazzelli et al.
2007; Na et al. 2007).
To date, tyrosinase has been a major target of whitening
agents like hydroquinone and arbutin, but their whitening
effects were insufficient and transient. Therefore, in this
study, we attempted to discover more effective depig-
mentation agents by screening plant extracts for novel
c-Kit inhibitors. The rational design of synthetic chemicals
sometimes yields the most potent and selective inhibitors
for therapeutic targets. However, plants and herbs provide
invaluable sources in the development of novel medicines
and novel scaffolds for therapeutic agents. Many com-
pounds derived from herbs and plants are highly bioactive
and merit development as drugs (Pieroni et al. 2004).
However, plant extracts typically contain high amounts of
fluorescent phytochemicals. Therefore, homogeneous high-
throughput screening methods like fluorescent resonance
energy transfer (FRET) are improper due to the high
background noise. In order to remove the difficulty of
internal fluorescence, we adopted a TRF assay that used
antibodies labeled with europium; Low backgrounds could
be achieved because of the time-difference between exci-
tation and emission fluorescence.
In this study, we found that the accelerated melanin
synthesis and proliferation induced by SCF were reduced
with the addition of diosmetin. This SCF-inhibitory effect
was equivalent to that of the reference compound (521232).
The results from the melanoderm tissue model implied that
60 lM diosmetin (0.0018 %) had higher efficacy than the
reference inhibitor, kojic acid (1 %), without any toxicity.
Furthermore, we assessed the allergenic potential of dios-
metin with a local lymph node assay in BALB/C mice. The
results showed that diosmetin did not induce an allergic
response; Stimulus index (S.I.) were between 0.8 and 1.1
based on the isolated lymph cells from lymph node after
3-day treatment of 10, 20 and 30 % diosmetin (25 lL) on
mice ears. In fact, diosmetin is already in use on the market
as an anti-oxidative skin stress agent (Kaden Biochemicals
GMBH, Germany); thus, its safety in one aspect has been
previously approved.
In summary, diosmetin, isolated from a C. morifolium
extract, showed dose-dependent inhibition of SCF-/UVB-
induced pigmentation and c-Kit phosphorylation. In
Fig. 6 MelanoDerm assay. After SCF (200 ng/mL) treatment for
three days, diosmetin (60 lM) or kojic acid (1 %) was applied, and
cells were incubated for two more weeks. Each melanoderm was fixed
with 10 % formalin and photos were taken from the top-view with a
phase contrast microscope at 9100 magnification
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addition, diosmetin effectively blocked increases in pro-
liferation and melanin synthesis induced by SCF in mouse
and human cells. Investigations with mouse NCCmelan5
cells, human primary melanocytes, and MelanoDerm tissue
showed diosmetin produced consistent anti-pigmentation
effects. Therefore, as c-Kit inhibitors diosmetin and
C. morifolium extracts could be potential candidates of
effective whitening agents.
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